REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gynecopharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Gynecopharma Gyogyszerkereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Gynecopharma Bt. is a company based in Hungary, with its head office in Beremend. It operates in the Pharmacies and Drug Stores sector. The company was established on September 25, 2000. The total number of employees is currently 6 (2024). The company’s latest financial report indicates a net sales revenue increase of 10.45% in 2023. Its’ total assets recorded a negative growth of 20.55%. In 2023, Gynecopharma Bt.’s net profit margin decreased by 0.15%.

Headquarters
Kossuth L utca 11.
Beremend; Baranya; Postal Code: 7827

Contact Details: Purchase the Gynecopharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Gynecopharma Bt. report to view the information.
Outstanding Shares:
Purchase the Gynecopharma Bt. report to view the information.
Registered Capital:
Purchase the Gynecopharma Bt. report to view the information.
Financial Auditors:
Purchase the Gynecopharma Bt. report to view the information.
Incorporation Date:
September 25, 2000
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Gynecopharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.45%▲
Total operating revenue
8.56%▲
Operating profit (EBIT)
-14.75%▼
EBITDA
-9.67%▼
Net Profit (Loss) for the Period
8.53%▲
Total assets
-20.55%▼
Total equity
6.44%▲
Operating Profit Margin (ROS)
-2.38%▼
Net Profit Margin
-0.15%▼
Return on Equity (ROE)
0.67%▲
Quick Ratio
-0.21%▼
Cash Ratio
0.2%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo